Edinburgh-based Craneware plc, a provider of software for the US healthcare market, said its revenue increased 9% to $189.3 million in the year ended June 30, 2024, and statutory profit before tax increased 20% to $15.7 million.
The company is proposing a final dividend of 16p per share, giving a total dividend for the year of 29p per share, up 2%.
Craneware said its strong sales performance was testament to the strength of its Trisus platform, the increasing success of its platform partnership programme “and the central role the group plays in enabling its customers to deliver better value healthcare.”
The Edinburgh firm said its new strategic alliance formed with Microsoft “enabling a joint go-to-market plan for Trisus offerings on the Microsoft Azure Marketplace” was expanding Craneware’s market reach.
Craneware said its momentum had continued post-year end, with good levels of trading and customer confidence, “providing the board with confidence in continued growth momentum for FY25, delivering on current expectations and the sustainable return to double digit growth rates.”
Craneware CEO Keith Neilson said: “The strong financial results during the year demonstrates the strength of the Trisus platform, our increasing platform partnership successes and the role we play in helping healthcare providers drive for better value in the US healthcare market.
“We see increased opportunity ahead. Our alliance with Microsoft will allow us to accelerate innovation and explore new AI-based applications in an efficient manner which, alongside the breadth of the Trisus platform, our unique data assets and our considerable and extensive customer base provides significant scope for expansion in the size of our addressable market.
“We approach this opportunity from a position of strength and resilience, with a strong balance sheet, high levels of recurring revenue and consistently high customer retention rates. This gives us the confidence and the ability to continue investing for growth, to secure our long-term market position.
“We have commenced FY25 with a good level of trading, and remain confident in achieving another positive year ahead, growth acceleration over the near term, and our ability to create further long-term value for all stakeholders.”